Pages Menu
Categories Menu

Posted on Aug 15, 2007 in News

Hybrid™ CPAP Mask Awarded New Fee Schedule

Business-Wire mini logo

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Teleflex Medical announced today that, effective July 1, 2007, CMS has issued a new fee schedule and HCPC reimbursement codes for the Hybrid CPAP Mask. The Hybrid is a revolutionary interface for use with sleep therapy systems in the treatment of obstructive sleep apnea. Consisting of an oral cushion that covers the mouth and two nasal pillows that fit into the nostrils, the Hybrid design simultaneously addresses two common concerns with continuous positive airway pressure (CPAP) therapy: patient comfort and oral leaks. By eliminating the pressure points across the bridge of the nose and on the forehead, the Hybrid delivers a more comfortable sleep experience, culminating in better therapy and a more compliant patient.

The Hybrid HCPC codes issued by CMS are K0553, K0554, K0555, and A7035.

“We are pleased with the response from CMS regarding the Hybrid HCPC reimbursement codes. By creating a brand new CPAP mask category for the Hybrid, CMS is recognizing the clinical efficacy of this innovative CPAP solution,” said Tim Hopper, vice president and general manager, Medical Products business unit of Teleflex Medical.

The Hybrid™ is part of Teleflex Medical’s existing family of Bravo™ and Nasal-Aire® II sleep therapy interfaces.

About Teleflex Medical Incorporated

Teleflex Medical Incorporated, a division of Teleflex Incorporated, is a leading global supplier of disposable medical products, surgical instruments and medical devices. The division supports health providers along the continuum of care in three main areas:

  • Devices for sleep therapy, respiratory care, anesthesia and urology

  • Surgical instruments and related services

  • Original equipment manufacturers

Teleflex Medical markets health care supplies under the HudsonRCI® and Rüsch® brand names and surgical instruments and medical devices under the Beere®, Deknatel®, KMedic®, Pilling® and Weck®brands.

About Teleflex Incorporated

Teleflex Incorporated (NYSE:TFX) is a diversified company with revenues in 2006 of more than $2.5 billion. Teleflex designs, manufactures and distributes quality-engineered products and services for the aerospace, automotive, industrial, marine, and medical markets worldwide. Headquartered in Limerick, Pa., with operations in 23 countries, Teleflex employs more than 19,000 people worldwide who focus on providing innovative solutions for customers. Additional information about Teleflex can be obtained from the company’s website at www.teleflex.com.

Bravo!™ and Hybrid™ are trademarks of RespCare Inc. Nasal-Aire® is a registered trademark of Innomed Technologies, Inc. Hudson RCI® and Deknatel® are registered trademarks of Teleflex Medical Incorporated. Beere®, KMedic®, Pilling® and Weck® are registered trademarks of Teleflex Incorporated. Rüsch® is a registered trademark of Willy Rüsch GmbH.

Contact
Teleflex Medical
Christianna Vance, 1-919-433-4808
cvance@teleflexmedical.com

 

Click here for our News Gallery.